The Training Component of the Immune Mediated Disorders after Allogeneic HCT Consortium will award a minimum of $50,000 annually to support career development for young investigators with an interest and aptitude for research in this field. Additional funds may be available from institutional resources committed to the PI, and at least one trainee will be supported each year. Trainees will be selected for financial support through an application process that will encourage women and minority candidates to apply. Additional career support will be available through the Consortium including access to data and specimens, participation in ongoing or planned studies, and funds for pilot projects conducted by mid-career investigators interested in reorienting their careers to study rare diseases. Trainees will also have access to training courses locally through the General Clinical Research Centers (GCRC), Clinical and Translational Science Awards (CTSA), Schools of Public Health or other coursework. Several week-long intensive courses supported by professional societies with relevance to the study of immune mediated disorders are also available. Potential mentors at each institution have been identified. Their letters of support and biosketches are provided.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-HOP-Y)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Fred Hutchinson Cancer Research Center
United States
Zip Code
Inamoto, Yoshihiro; Martin, Paul J; Storer, Barry E et al. (2014) Association of severity of organ involvement with mortality and recurrent malignancy in patients with chronic graft-versus-host disease. Haematologica 99:1618-23
Inamoto, Yoshihiro; Flowers, Mary E D; Sandmaier, Brenda M et al. (2014) Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. Blood 124:1363-71
El-Jawahri, Areej; Pidala, Joseph; Inamoto, Yoshi et al. (2014) Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease. Biol Blood Marrow Transplant 20:1341-8
Inamoto, Yoshihiro; Pidala, Joseph; Chai, Xiaoyu et al. (2014) Assessment of joint and fascia manifestations in chronic graft-versus-host disease. Arthritis Rheumatol 66:1044-52
Palmer, Jeanne; Williams, Kirsten; Inamoto, Yoshihiro et al. (2014) Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biol Blood Marrow Transplant 20:337-44
Kitko, Carrie L; Levine, John E; Storer, Barry E et al. (2014) Plasma CXCL9 elevations correlate with chronic GVHD diagnosis. Blood 123:786-93
Inamoto, Yoshihiro; Kim, Dennis D; Storer, Barry E et al. (2014) Application of CIBMTR risk score to NIH chronic GVHD at individual centers. Blood 123:453-5
Allen, Jessica L; Tata, Prasanthi V; Fore, Matthew S et al. (2014) Increased BCR responsiveness in B cells from patients with chronic GVHD. Blood 123:2108-15
Duarte, R F; Greinix, H; Rabin, B et al. (2014) Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. Bone Marrow Transplant 49:49-54
Inamoto, Y; Jagasia, M; Wood, W A et al. (2014) Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. Bone Marrow Transplant 49:532-8

Showing the most recent 10 out of 11 publications